About DESTINY-Ovarian01 DESTINY-Ovarian01 is a global, multicenter, randomized, open-label, phase 3 trial evaluating the efficacy and safety of ENHERTU (5.4 mg/kg) in combination with bevacizumab ...

Bungie announces plans to completely overhaul Destiny 2's current bounty and seasonal challenges, replacing it with the new Orders system. Bungie continues to tweak and change the current gameplay ...

The first patient has been dosed in the randomization phase of the DESTINY-Ovarian01 phase 3 trial evaluating ENHERTU ® (trastuzumab deruxtecan) in combination with bevacizumab versus bevacizumab ...

Derek's love of games came at an early age when his parents first brought home the Nintendo Entertainment System. From then on, countless nights were spent hunting ducks, stomping turtles, exploring ...